Catheter Precision Inc. (NYSE AMERICAN: VTAK)
$0.3420
+0.0120 ( -4.97% ) 28.7K
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Market Data
Open
$0.3420
Previous close
$0.3300
Volume
28.7K
Market cap
$2.64M
Day range
$0.3390 - $0.3520
52 week range
$0.3110 - $8.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 10, 2024 |
4 | Insider transactions | 1 | Jan 10, 2024 |
4 | Insider transactions | 1 | Jan 10, 2024 |
3 | Insider transactions | 1 | Jan 08, 2024 |
8-k | 8K-related | 14 | Jan 04, 2024 |
8-k | 8K-related | 14 | Dec 29, 2023 |
8-k | 8K-related | 16 | Dec 22, 2023 |
10-q | Quarterly Reports | 97 | Dec 21, 2023 |
8-k | 8K-related | 19 | Dec 18, 2023 |
10-q | Quarterly Reports | 97 | Dec 15, 2023 |